DermTech, Inc.·4

Sep 12, 8:07 PM ET

Sun Kevin M 4

4 · DermTech, Inc. · Filed Sep 12, 2023

Insider Transaction Report

Form 4
Period: 2023-09-08
Sun Kevin M
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-09-08$1.93/sh2,703$5,217289,615 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh223$430292,318 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh3,058$5,902286,557 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh3,196$6,168283,361 total
  • Sale

    Common Stock

    2023-09-11$1.89/sh436$824282,925 total
Footnotes (6)
  • [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
  • [F2]Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2023.
  • [F3]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022.
  • [F4]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 7, 2023.
  • [F5]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.
  • [F6]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 24, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION